Israel - engelska - Ministry of Health

inovamed pharma ltd, israel - carbidopa; entacapone; levodopa - film coated tablets - levodopa 50 mg; carbidopa 12.5 mg; entacapone 200 mg - levodopa and decarboxylase inhibitor - levodopa and decarboxylase inhibitor - treatment of patients with parkinson's disease and end-of-dose motor fluctuations not stabilised on levodopa/dopa decarboxylase (ddc) inhibitor treatment.

Israel - engelska - Ministry of Health

inovamed pharma ltd, israel - carbidopa; entacapone; levodopa - film coated tablets - levodopa 150 mg; carbidopa 37.5 mg; entacapone 200 mg - levodopa and decarboxylase inhibitor - levodopa and decarboxylase inhibitor - treatment of patients with parkinson's disease and end-of-dose motor fluctuations not stabilised on levodopa/dopa decarboxylase (ddc) inhibitor treatment.

Israel - engelska - Ministry of Health

novartis israel ltd - olopatadine as hydrochloride - eye drops - olopatadine as hydrochloride 1 mg/ml - olopatadine - olopatadine - for the temporary prevention of itching of the eye due to allergic conjunctivitis.

Irland - engelska - HPRA (Health Products Regulatory Authority)

martindale pharmaceuticals ltd - cefuroxime sodium - pdr for soln for injection - 750 base milligrams

Irland - engelska - HPRA (Health Products Regulatory Authority)

martindale pharmaceuticals ltd - cefuroxime sodium - pdr for soln for injection - 1.5 grams

Irland - engelska - HPRA (Health Products Regulatory Authority)

martindale pharmaceuticals ltd - topotecan hydrochloride - pdr/conc/soln for infus - 4 milligram

Irland - engelska - HPRA (Health Products Regulatory Authority)

martindale pharmaceuticals ltd - topotecan hydrochloride - pdr/conc/soln for infus - 1 milligram

Storbritannien - engelska - myHealthbox

essential pharmaceuticals ltd - dexamfetamine sulfate - oral solution - 1mg/ml - psychoanaleptics; psychostimulants, agents used for adhd and nootropics; centrally acting sympathomimetics - it is indicated in the treatment of narcolepsy in adults

Storbritannien - engelska - myHealthbox

caduceus pharma ltd - atorvastatin - film-coated tablets - 10mg - lipid modifying agents, hmg-coa-reductase inhibitors - it is indicated as an adjunct to diet for reduction of elevated total cholesterol (total-c), ldl-cholesterol (ldl-c), apolipoprotein b, and triglycerides in adults adolescents and children aged 10 years or older or older with primary hypercholesterolaemia including familial hypercholesterolaemia (heterozygous variant) or combined (mixed) hyperlipidaemia (corresponding to types iia and iib of the fredrickson classification) when response to diet and other nonpharmacological measures is inadequate.

Storbritannien - engelska - myHealthbox

caduceus pharma ltd - atorvastatin - film-coated tablets - 20mg - lipid modifying agents, hmg-coa-reductase inhibitors, - it is indicated as an adjunct to diet for reduction of elevated total cholesterol (total-c), ldl-cholesterol (ldl-c), apolipoprotein b, and triglycerides in adults adolescents and children aged 10 years or older or older with primary hypercholesterolaemia including familial hypercholesterolaemia (heterozygous variant) or combined (mixed) hyperlipidaemia (corresponding to types iia and iib of the fredrickson classification) when response to diet and other nonpharmacological measures is inadequate.